GenDx develops excellent molecular transplant diagnostic tools making an important contribution to new developments in worldwide healthcare, especially within the transplant community. Furthermore and in line with our social responsibility, GenDx actively supports causes and institutions to improve the quality of life of transplant patients.
18th International HLA & Immunogenetics Workshop
GenDx supports the 18th International HLA & Immunogenetics Workshop and sponsors the IHIWS database. For more information please visit https://www.ihiw18.org/.
GenDx is proud sponsor of the International Immunogenetics Information system (IMGT database), globally used and daily reference for the whole HLA community. For more information please visit https://www.ebi.ac.uk/ipd/imgt/hla/.
Stem Cell Donor Recruitment Day
GenDx supports MatchIs, the Dutch center for stem cell donors. Together with MatchIs, we have developed an one-day campaign, the ‘Stem Cell Donor Registry Day’, focused on increasing awareness of the issue of lack of stem-cell donors and recruiting new young donors in our local community. GenDx employees volunteer for this campaign and work together with Matchis on recruiting many new donors. For more information about MatchIs visit https://www.matchis.nl/.
Allele Frequency Net Database
GenDx is a proud sponsor of the AFDN (Allele Frequency Net Database) website. AFND is a very useful tool for researchers as they can search population frequencies of several immune genes such as Human Leukocyte Antigens (HLA), Killer-cell Immunoglobulin-like Receptors (KIR), Major histocompatibility complex class I chain-related (MIC) genes, and a number of cytokine gene polymorphisms. It contains information at allele, haplotype and genotype level depending on the polymorphism. AFND is currently maintained by researchers at Royal Liverpool University Hospital and the University of Liverpool, in collaboration with other international scientific groups.
In GenDx we realize the importance of working together to get to our goals and bring our vision to life. Together with our partners, we aim at the common goal, to improve the quality of life and survival of transplant patients.
PIRCHE stands for Predicted Indirectly ReCognizable HLA Epitopes. Their mission is to provide medical prediction of unprecedented significance to support decisions on solid organ and stem cell transplantations by means of matching human leukocyte antigens (HLA) on the basis of epitopes. To this end, it is their strategy to run an immersive digital diagnostic platform that provides health professionals with the most accurate scores for improved transplantation outcomes. The basic scientific work for this groundbreaking technology was done at the University Medical Center Utrecht (UMCU) in The Netherlands by Dr. Eric Spierings and his team.
For more information about PIRCHE visit www.pirche.com